Navigation Links
BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
Date:10/22/2007

SAN ANTONIO, Oct. 22 /PRNewswire/ -- BioMedical Enterprises, Inc. (BME), a privately held medical device company and leader in orthopedic shape memory implant technology, today announced that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the OSSpine(TM) for use in anterior fixation of the cervical spine to provide enhanced biomechanical stability & bone graft retention. The patent-pending OSSpine(TM) builds on the extremity bone fusion success of BME's OSStaple(TM) and OSSplate(TM), and joins the Step OSStaple(TM) and the OSSArc(TM) dynamic residual compression implants as the most recent additions to BME's OSSforce(TM) Fixation System.

Made of nitinol, a biocompatible alloy possessing shape memory and super-elastic properties, the OSSpine(TM) implant is inserted while in its malleable state at room temperature. Using BME's patent-pending OSSforce(TM) Implant Controller, the implant is safely heated to activate its shape change and impart compression forces across the fusion site. During this process, the implant's legs close and it's s-shaped back shrinks providing uniform compression while the alloy's structure transforms into a state approximately 20% stronger then 316L stainless steel. The OSSpine(TM) implant actively compresses the fusion construct compensating for any graft subsidence that may occur during healing.

BME recently announced that it had received a Notice of Allowance from the United States Patent and Trademark Office for 61 claims providing protection for their innovative OSSforce(TM) Implant Controller technology. The OSSpine(TM) implants and the OSSforce(TM) Implant Controller will be showcased by BME at the North American Spine Society (NASS) 22nd Annual Meeting being held October 23-27, 2007 in Austin, Texas.

BioMedical Enterprises, Inc. (BME) is a medical device company that addresses the changing needs in musculoskeletal medicine. BME focuses on minimally invasive orthopaedic ins
'/>"/>

SOURCE BioMedical Enterprises, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Biomedical engineering conference invites manufacturers
2. Manufacturing partnership will move into biotech and biomedical spaces
3. Biomedical Alliance about more than stem cells
4. Doyle seeks $2.5M for biomedical alliance
5. Students will show off biomedical devices to professors and investors
6. Biomedical alliance marks first full year
7. UW Biomedical Engineering awarded $2.9 million research grant
8. Having two biomedical tech centers in Wisconsin will help the state
9. New biomedical institute aims to unite business and academia in SE Wisconsin
10. Wisconsin publicly traded biomedical companies report gains this quarter
11. Medical College receives $377K to study brain disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)... Mass., Sept. 5 /- Men living in West... with an enlarged prostate,now have the option of ...em. biolitec, Inc. is pleased to announce that a n...g its breakthrough LIFE(TM) (Laser Induced,Flow En...erplasia (BPH),that quickly and gently eliminates ...
(Date:9/5/2008)...ifornia, September 5 /-, - Exchange:...th 2008 a name change to,Fountain Healthy Aging In...l follows the earlier,approval of the name change ...the Company., CEO, Dr Tony Jimenez said a name ch...nd a completely new business plan ", Dr Jimenez w...
(Date:9/5/2008)...and, September 5 /- The 33rd ESMO Con...in Oncology, serves as a,meeting place for medical...,ideas with colleagues from other disciplines., T...iplinary,interaction, a teaching ground, and a pla...y such as cancer research in Europe, the training ...
(Date:9/5/2008)..., Sept. 5 /- Expression Genetics, Inc...TheraPlas(R) cancer drug,has been selected as one ...development available for strategic partnering. Th...ssembled by Windhover Information, a leading,provi...to senior executives,in the pharmaceutical, biotec...
Breaking Biology Technology:Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon 2Immureboost Inc Announces a Change of Name to Fountain Healthy Aging Inc 233rd ESMO Congress in Stockholm, 12-16 September 2008 233rd ESMO Congress in Stockholm, 12-16 September 2008 333rd ESMO Congress in Stockholm, 12-16 September 2008 433rd ESMO Congress in Stockholm, 12-16 September 2008 5Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover 2Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover 3
...mplementary nanotechnology companies, Imago Scien...British firm. , ,Imago announced Tuesday that it h...nce Ltd. from the UK-based Polaron Plc. The purcha...kes Imago the world,s largest atom probe supplier,...e companies have a great deal in common, including...
...m popularized by columnist Tom Friedman, requires ...ent requires continuous learning and development o... succeed in flat world competition better be creat...o attract and retain the high-caliber talent they ...? It isn,t easy and doesn,t happen overnight. But ...
...ol that might play an important role in rapidly de...piratory illnesses is close to passing a validatio...Hospital and Clinics. , ,The MultiCode panel techn...nces , a Madison biotechnology company, received t...ssor of pediatrics at UW-Madison. Gern, a pediatri...
...either conveniently mobile, nor completely the Int...torage to support a rich Web experience, and mobil...heap enough to support an always-connected browsin...cess to information. So even while we,re frustrate...xperience. , ,This situation is what Seattle-based...
Other Biology Technology:Imago acquires synergistic British firm 2Seven talent management practices that matter 2Seven talent management practices that matter 3Seven talent management practices that matter 4Seven talent management practices that matter 5EraGen diagnostic passes UW tests, could quickly detect bird flu 2EraGen diagnostic passes UW tests, could quickly detect bird flu 3Webaroo aims to make mobile search relevant 2
(Date:9/4/2008)...sts have discovered a gene enhancer, known as HACN...the uniquely opposable human thumb, and possibly a...humans to walk on two legs, according to a paper p...tudy is the first to provide evidence of the exist...witches near genes in the human genome. , Dr. ...
(Date:9/4/2008)...ATINew research from the University of Cincinnati ...ce hard plasticsbisphenol A (BPA)as a risk factor ...n a laboratory study, using fresh human fat tissue...mone, adiponectin, which is responsible for regula...le at a substantially higher risk for metabolic sy...
(Date:9/4/2008)...COLD SPRING HARBOR, N.Y. (Sept. 4, 2008) A varie...nd animalshave biological rhythms, where the timin... is naturally adjusted to allow them to adapt and ...itions. In recent years, significant advances hav...hese rhythms and how they translate into modificat...
(Date:9/4/2008)...tem cell research is the next great leap in medici...y could replace a failing heart, or new cells take...han using stem cells from embryonic sources, which...c issues, scientists have been looking to adult hu...dult stem cells are now being cultivated from vari...
Breaking Biology News(10 mins):Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3Bisphenol A linked to metabolic syndrome in human tissue 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2Tel Aviv University researchers create new stem cell screening tool 2Researchers disprove long standing belief about HIV treatment 24383 1Researchers disprove long standing belief about HIV treatment 24383 2Researchers disprove long standing belief about HIV treatment 24383 3Plant steroids offer new paradigm for how hormones work 4199 1Plant steroids offer new paradigm for how hormones work 4199 2Plant steroids offer new paradigm for how hormones work 4199 3Jury Award to Englewood Company to Total More Than 241 Million for Breach of Fiduciary Duties in Shareholder Class Action Case 24379 1Jury Award to Englewood Company to Total More Than 241 Million for Breach of Fiduciary Duties in Shareholder Class Action Case 24379 2FDA Grants Pediatric Exclusivity for TOPAMAX 28R 29 Extending the Marketing Exclusivity by Six Months 2708 1FDA Grants Pediatric Exclusivity for TOPAMAX 28R 29 Extending the Marketing Exclusivity by Six Months 2708 2FDA Grants Pediatric Exclusivity for TOPAMAX 28R 29 Extending the Marketing Exclusivity by Six Months 2708 3
...ofessor Mark Pagani in the Department of Geology a...e first detailed history of atmospheric carbon dio...able isotopes of carbon in a National Science Foun...gh the energy we consume, each of us makes a contr...arbon dioxide and methane, in the Earth,s atmosphe...
...tricting calories over decades may add a few years...to live to 125 and beyond, as many have speculated...s that suffering years of misery to remain super-s...f a longer life," said UCLA evolutionary biologist...striction may not make you live forever, but it su...
...ediately notice if the outside world suddenly went...e of our blinks, even though they cause a similar ... So why are we not aware of the frequent mini-blac... discovered that visual sensitivity begins decreas...anisms underlying this process have until now rema...
...ontreal researchers has discovered that GCN2, a pr... information into long-term memory, may be a maste...term memory. Their paper Translational control of ...eIF2a kinase GCN2, which was published in the Augu...first genetic evidence that protein synthesis is c...
Other Biology News:Invasive parasite destroying fish species 2Caloric restriction won't dramatically extend life span in humans: UCLA research 2Caloric restriction won't dramatically extend life span in humans: UCLA research 3Blink, and the brain misses it 2Montreal researchers probe the genetic basis of memory 2
T7Select Biopanning Kit from Novagen
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180
Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7
TaqMan Rodent GAPDH Control Reagents from Applied Biosystems
Biology Products: